StockDrifts LogoStockDrifts

curacle 365270

Company
큐라클curacle
Insiders
3
Buys
3
Total Value
₩1.4B ($962K)
Avg Return
+34.27%
Last Filing
2026-06-08

curacle (365270) has 3 disclosed insider purchases and 1 disclosed disposals on record, filed by 3 distinct insiders. Together those filings cover ₩1.4B ($962K) in reported transaction value. The earliest filing StockDrifts holds for curacle is dated 2024-03-11; the most recent is 2026-06-08. Across these filings the average return since disclosure is +34.27%, measured from each filing date to the latest available close.

Price & insider activity (12 months)

Recent insider trades

DateTypeSourceInsiderPositionSharesPrice at filingReturnValue
2026-06-08BUYPROGRAM
김정한
Kim Jeong-han
Managing Director8.0K₩11,000+22.7%₩88M ($61K)
2026-06-08BUYPROGRAM
이원일
Wonil Lee
Managing Director5.0K₩11,000+22.7%₩55M ($38K)
2026-06-08BUYPROGRAM
표정인
facial expression
moving20.0K₩11,000+22.7%₩220M ($153K)
2026-06-08BUYPROGRAM
추연성
inference
Other non-executive directors10.0K₩11,000+22.7%₩110M ($76K)
2026-06-08BUYPROGRAM
황용
Hwang Yong
moving4.0K₩11,000+22.7%₩44M ($31K)
2026-06-08BUYPROGRAM
최재진
Jaejin Choi
Managing Director8.0K₩11,000+22.7%₩88M ($61K)
2025-09-24BUYMarket Buy
최동훈
Choi Dong-hoon
Outside Director600₩6,380+153.6%₩4M ($3K)
2025-09-22BUYMarket Buy
최동훈
Choi Dong-hoon
Outside Director2.0K₩6,030+168.3%₩12M ($8K)
2025-09-11BUY유상신주취득
권영근
Younggeun Kwon
Chairman of the Board271.2K₩7,330+120.7%₩2.0B ($1.4M)
2025-09-11SELL기타
권영근
Younggeun Kwon
Chairman of the Board-271.2K₩7,330-120.7%₩2.0B ($1.4M)
2025-09-11BUY유상신주취득
황용
Hwang Yong
moving10.0K₩7,330+120.7%₩73M ($51K)
2025-09-11SELL기타
황용
Hwang Yong
moving-9.0K₩7,330-120.7%₩66M ($46K)
2025-07-24SELL장외매도
권영근
Younggeun Kwon
Chairman of the Board-632.8K₩5,070-219.1%₩3.2B ($2.2M)
2025-07-24SELLMarket Sell
권영근
Younggeun Kwon
Chairman of the Board-270.0K₩5,070-219.1%₩1.4B ($951K)
2025-07-18BUY기타
황용
Hwang Yong
moving9.0K₩5,450+196.9%₩49M ($34K)
2025-07-18BUY기타
김영명
Youngmyeong Kim
Other non-executive directors20.0K₩5,450+196.9%₩109M ($76K)
2025-07-18BUY기타
권영근
Younggeun Kwon
Chairman of the Board903.9K₩5,450+196.9%₩4.9B ($3.4M)
2024-04-30SELL시간외매매
이인규
Lee In-gyu
--442.5K₩15,694-3.1%₩6.9B ($4.8M)
2024-03-11BUYPROGRAM
김정한
Kim Jeong-han
Managing Director608---

Frequently asked questions

Who has been buying curacle stock?
3 distinct insiders have filed 3 disclosed insider purchases in curacle (365270), most recently on 2026-06-08. Each filer, their role, the number of shares and the price at filing are listed in the table on this page.
How many insider filings does curacle have?
curacle has 3 buy-side and 1 sell-side disclosures on record, covering ₩1.4B ($962K) in total reported value, spanning 2024-03-11 to 2026-06-08.
Do insider buys in Korean stocks predict returns?
Not uniformly. StockDrifts analysed 170,720 share-count changes across 56,930 Korean regulatory filings using cross-sectional alpha at fixed forward horizons, and found returns concentrated in particular signal tiers rather than in insider buying generally.

More on this data

Every trade listed above comes from an official regulatory disclosure. For how StockDrifts scores these disclosures, see the Korea insider signal tier research, or browse every Korean stock we track.